| Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance S Keyvani-Ghamsari, K Khorsandi, A Rasul, MK Zaman Clinical Epigenetics 13 (1), 120, 2021 | 45 | 2021 |
| Curcumin effect on cancer cells' multidrug resistance: an update S Keyvani‐Ghamsari, K Khorsandi, A Gul Phytotherapy research 34 (10), 2534-2556, 2020 | 45 | 2020 |
| Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities K Khorsandi, R Hosseinzadeh, H Sadat Esfahani, S Keyvani-Ghamsari, ... Expert Review of Anti-infective Therapy 19 (10), 1299-1323, 2021 | 36 | 2021 |
| Effect of irinotecan on HMGB1, MMP9 expression, cell cycle, and cell growth in breast cancer (MCF-7) cells S Keyvani-Ghamsari, A Rabbani-Chadegani, J Sargolzaei, ... Tumor Biology 39 (4), 1010428317698354, 2017 | 25 | 2017 |
| A mechanistic perspective on targeting bacterial drug resistance with nanoparticles K Khorsandi, S Keyvani-Ghamsari, F Khatibi Shahidi, R Hosseinzadeh, ... Journal of Drug Targeting 29 (9), 941-959, 2021 | 16 | 2021 |
| Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin A Rabbani-Chadegani, S Keyvani-Ghamsari, N Zarkar Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 84 (1 …, 2011 | 16 | 2011 |
| An update on the potential mechanism of gallic acid as an antibacterial and anticancer agent S Keyvani‐Ghamsari, M Rahimi, K Khorsandi Food Science & Nutrition 11 (10), 5856-5872, 2023 | 11 | 2023 |
| Targeting ferroptosis in melanoma: cancer therapeutics P K khorsandi, HS Esfahani , S Keyvani-Ghamsari Cell Communication and Signaling 21 21 (337), 2023 | 1 | 2023 |
